Tenosiprol

Tenosiprol

SCHEMBL9201976

O=C(OC1CNC(C(=O)O)C1)c1cccs1

nearest known ligand 0.59

Full drug profile on Sugi Atlas →

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
DAO P14920 1/20 0.41
NPC1 O15118 4/20 0.40
RAB9A P51151 4/20 0.40
MAPT P10636 2/20 0.40
KMT2A Q03164 2/20 0.40
LMNA P02545 1/20 0.40
TSHR P16473 1/20 0.39
MAPK1 P28482 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
HPGD P15428 2/20 0.39
PKM P14618 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
CES2 O00748 1/20 0.39
CES1 P23141 1/20 0.39
ALDH1A1 P00352 1/20 0.38
HPGDS O60760 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Tenosiprol SCHEMBL2109048 1.00 DAO (0.41) DAONPC1RAB9AMAPTKMT2A
SCHEMBL9203491 0.82 DAO (0.40) DAONPC1RAB9AMAPTKMT2A
SCHEMBL3448795 0.80 CHRNA7 (0.55) KMT2A
SCHEMBL27897636 0.80 CHRNA7 (0.55) KMT2A
SCHEMBL27897614 0.80 CHRNA7 (0.55) KMT2A
SCHEMBL3448793 0.80 CHRNA7 (0.55) KMT2A
Hydrochloric Acid SCHEMBL5518835 0.78 CHRNA7 (0.54) KMT2A
SCHEMBL9581895 0.77 CES2 (0.50) DAONPC1RAB9AMAPTKMT2A
SCHEMBL24354951 0.75 CHRNA7 (0.50) KMT2A
SCHEMBL3195638 0.74 TSHR (0.53) DAONPC1RAB9AMAPTKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0532506-B1 4-[(Thiophene-2-carbonyl)oxy]pyrrolidine-2-carboxylic acid, its preparation and its use as anti-inflammatory and anti-dystrophic agent PULITZER ITALIANA (IT) 1995-10-18 EP claimed
EP-0532506-B1 4-[(Thiophene-2-carbonyl)oxy]pyrrolidine-2-carboxylic acid, its preparation and its use as anti-inflammatory and anti-dystrophic agent PULITZER ITALIANA (IT) 1995-10-18 EP disclosed
EP-0532506-B1 4-[(Thiophene-2-carbonyl)oxy]pyrrolidine-2-carboxylic acid, its preparation and its use as anti-inflammatory and anti-dystrophic agent PULITZER ITALIANA (IT) 1995-10-18 EP disclosed
EP-0532506-B1 4-[(Thiophene-2-carbonyl)oxy]pyrrolidine-2-carboxylic acid, its preparation and its use as anti-inflammatory and anti-dystrophic agent PULITZER ITALIANA (IT) 1995-10-18 EP disclosed
EP-0532506-A1 HYDROXYPROLINE DERIVATIVE, A PROCESS FOR THE PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING IT. PULITZER ITALIANA (IT) 1993-03-24 EP disclosed
EP-0532506-A1 HYDROXYPROLINE DERIVATIVE, A PROCESS FOR THE PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING IT. PULITZER ITALIANA (IT) 1993-03-24 EP disclosed
WO-1991018896-A1 HYDROXYPROLINE DERIVATIVE, A PROCESS FOR THE PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING IT PULITZER ITALIANA S.R.L. (IT) 1991-12-12 WO disclosed
WO-1991018896-A1 HYDROXYPROLINE DERIVATIVE, A PROCESS FOR THE PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING IT PULITZER ITALIANA S.R.L. (IT) 1991-12-12 WO disclosed